NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

Skit, I agree, if the FDA were to grant a blanket approval for all solid cancers, I have little doubt that they would require follow-up PIV trials to follow up in a well organized fashion how well the treatment works in each of the indications. This of course would be important for further treatment development for each indication. This would far superior than trying to glean in an ad hoc fashion whatever information can be obtained from any off label use by Dr's in a chaotic and disorganized fashion.